awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38152742-02DE3FD5-CBD8-427F-9116-ECFB81B83F7B
Q38152742-02DE3FD5-CBD8-427F-9116-ECFB81B83F7B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38152742-02DE3FD5-CBD8-427F-9116-ECFB81B83F7B
Optimal sequencing of anti-HER2 therapy throughout the continuum of HER2-positive breast cancer: evidence and clinical considerations.
P2860
Q38152742-02DE3FD5-CBD8-427F-9116-ECFB81B83F7B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38152742-02DE3FD5-CBD8-427F-9116-ECFB81B83F7B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
37c3902c0c3882cff87a7e8bb8b21cf64904986d
P2860
Adjuvant trastuzumab in HER2-positive breast cancer.